# A Trial of Vitamin B12 in Septic Shock

> **NCT03783091** · PHASE2 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 20 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Hydroxocobalamin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03783091
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-05
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783091, "A Trial of Vitamin B12 in Septic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03783091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*